Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNS Effects of Two HIV Integrase Inhibitor Regimens
2014-003710-84Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dolutegravir, raltegravir and emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Imperial College London. Primary endpoint: Cerebral function parameters. Started Nov 2014; status: completed.
02
Drugs
dolutegravirraltegraviremtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-003710-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003710-84.